{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:10:20Z","timestamp":1739279420568,"version":"3.37.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,11]]},"DOI":"10.7759\/cureus.78849","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:41:56Z","timestamp":1739277716000},"source":"Crossref","is-referenced-by-count":0,"title":["Toxicity and Oncologic Outcomes of Proton Radiotherapy for Oropharyngeal Cancer: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Niema B","family":"Razavian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel F","family":"Shenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph B","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan T","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.02.029","article-title":"Proton radiation therapy for head and neck cancer: a review of the clinical experience to date","volume":"89","author":"Holliday EB","year":"2014","unstructured":"Holliday EB, Frank SJ. Proton radiation therapy for head and neck cancer: a review of the clinical experience to date. Int J Radiat Oncol Biol Phys. 2014, 89:292-302. 10.1016\/j.ijrobp.2014.02.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-22-00030.1","article-title":"Proton beam radiation therapy for oropharyngeal squamous cell carcinoma","volume":"9","author":"Mendenhall WM","year":"2023","unstructured":"Mendenhall WM, Beitler JJ, Saba NF, et al.. Proton beam radiation therapy for oropharyngeal squamous cell carcinoma. Int J Part Ther. 2023, 9:243-52. 10.14338\/IJPT-22-00030.1","journal-title":"Int J Part Ther"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2013.05.001","article-title":"Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison","volume":"38","author":"Kandula S","year":"2013","unstructured":"Kandula S, Zhu X, Garden AS, et al.. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim. 2013, 38:390-4. 10.1016\/j.meddos.2013.05.001","journal-title":"Med Dosim"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.02.021","article-title":"Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma","volume":"95","author":"Gunn GB","year":"2016","unstructured":"Gunn GB, Blanchard P, Garden AS, et al.. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys. 2016, 95:360-7. 10.1016\/j.ijrobp.2016.02.021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.06.057","article-title":"A prospective study of mucosal sparing radiation therapy in resected oropharyngeal cancer patients","volume":"115","author":"Anderson JD","year":"2023","unstructured":"Anderson JD, DeWees TA, Ma DJ, et al.. A prospective study of mucosal sparing radiation therapy in resected oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 2023, 115:192-201. 10.1016\/j.ijrobp.2022.06.057","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2022.4165","article-title":"Osteoradionecrosis of the jaw following proton radiation therapy for patients with head and neck cancer","volume":"149","author":"Singh A","year":"2023","unstructured":"Singh A, Kitpanit S, Neal B, et al.. Osteoradionecrosis of the jaw following proton radiation therapy for patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2023, 149:151-9. 10.1001\/jamaoto.2022.4165","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2017.12.002","article-title":"Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: the journey from clinical trial concept to activation","volume":"28","author":"Frank SJ","year":"2018","unstructured":"Frank SJ, Blanchard P, Lee JJ, et al.. Comparing intensity-modulated proton therapy with intensity-modulated photon therapy for oropharyngeal cancer: the journey from clinical trial concept to activation. Semin Radiat Oncol. 2018, 28:108-13. 10.1016\/j.semradonc.2017.12.002","journal-title":"Semin Radiat Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2022.11.010","article-title":"TORPEdO: a phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson DJ","year":"2023","unstructured":"Thomson DJ, Cruickshank C, Baines H, et al.. TORPEdO: a phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer. Clin Transl Radiat Oncol. 2023, 38:147-54. 10.1016\/j.ctro.2022.11.010","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.04.018","article-title":"Cost-effectiveness analysis of intensity modulated radiation therapy versus proton therapy for oropharyngeal squamous cell carcinoma","volume":"101","author":"Sher DJ","year":"2018","unstructured":"Sher DJ, Tishler RB, Pham NL, Punglia RS. Cost-effectiveness analysis of intensity modulated radiation therapy versus proton therapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2018, 101:875-82. 10.1016\/j.ijrobp.2018.04.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma V","year":"2016","unstructured":"Verma V, Mishra MV, Mehta MP. A systematic review of the cost and cost-effectiveness studies of proton radiotherapy. Cancer. 2016, 122:1483-501. 10.1002\/cncr.29882","journal-title":"Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): development and validation of a new instrument","volume":"73","author":"Slim K","year":"2003","unstructured":"Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003, 73:712-6. 10.1046\/j.1445-2197.2003.02748.x","journal-title":"ANZ J Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis","volume":"120","author":"Blanchard P","year":"2016","unstructured":"Blanchard P, Garden AS, Gunn GB, et al.. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis. Radiother Oncol. 2016, 120:48-55. 10.1016\/j.radonc.2016.05.022","journal-title":"Radiother Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes","volume":"95","author":"Sio TT","year":"2016","unstructured":"Sio TT, Lin HK, Shi Q, et al.. Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes. Int J Radiat Oncol Biol Phys. 2016, 95:1107-14. 10.1016\/j.ijrobp.2016.02.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2017.09.008","article-title":"Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer","volume":"7","author":"Jensen GL","year":"2017","unstructured":"Jensen GL, Blanchard P, Gunn GB, et al.. Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer. Clin Transl Radiat Oncol. 2017, 7:28-35. 10.1016\/j.ctro.2017.09.008","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.05.006","article-title":"Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer","volume":"123","author":"Zhang W","year":"2017","unstructured":"Zhang W, Zhang X, Yang P, et al.. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol. 2017, 123:401-5. 10.1016\/j.radonc.2017.05.006","journal-title":"Radiother Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-18-00032.1","article-title":"Quality of life of postoperative photon versus proton radiation therapy for oropharynx cancer","volume":"5","author":"Sharma S","year":"2018","unstructured":"Sharma S, Zhou O, Thompson R, et al.. Quality of life of postoperative photon versus proton radiation therapy for oropharynx cancer. Int J Part Ther. 2018, 5:11-7. 10.14338\/IJPT-18-00032.1","journal-title":"Int J Part Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-19-00053.1","article-title":"Proton therapy for locally advanced oropharyngeal cancer: initial clinical experience at the University of Washington","volume":"6","author":"Aljabab S","year":"2020","unstructured":"Aljabab S, Liu A, Wong T, Liao JJ, Laramore GE, Parvathaneni U. Proton therapy for locally advanced oropharyngeal cancer: initial clinical experience at the University of Washington. Int J Part Ther. 2020, 6:1-12. 10.14338\/IJPT-19-00053.1","journal-title":"Int J Part Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.12.055","article-title":"A model-based approach to predict short-term toxicity benefits with proton therapy for oropharyngeal cancer","volume":"104","author":"Rwigema JM","year":"2019","unstructured":"Rwigema JM, Langendijk JA, van der Laan HP, Lukens JN, Swisher-McClure SD, Lin A. A model-based approach to predict short-term toxicity benefits with proton therapy for oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2019, 104:553-62. 10.1016\/j.ijrobp.2018.12.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.07.012","article-title":"Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy","volume":"142","author":"Bagley AF","year":"2020","unstructured":"Bagley AF, Ye R, Garden AS, et al.. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol. 2020, 142:133-9. 10.1016\/j.radonc.2019.07.012","journal-title":"Radiother Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.04.021","article-title":"Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer","volume":"148","author":"Grant SR","year":"2020","unstructured":"Grant SR, Hutcheson KA, Ye R, et al.. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol. 2020, 148:133-9. 10.1016\/j.radonc.2020.04.021","journal-title":"Radiother Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.03.010","article-title":"Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer","volume":"147","author":"Manzar GS","year":"2020","unstructured":"Manzar GS, Lester SC, Routman DM, et al.. Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancer. Radiother Oncol. 2020, 147:64-74. 10.1016\/j.radonc.2020.03.010","journal-title":"Radiother Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-20-00081.1","article-title":"Patient-reported outcomes after intensity-modulated proton therapy for oropharynx cancer","volume":"8","author":"Bahig H","year":"2021","unstructured":"Bahig H, Gunn BG, Garden AS, et al.. Patient-reported outcomes after intensity-modulated proton therapy for oropharynx cancer. Int J Part Ther. 2021, 8:213-22. 10.14338\/IJPT-20-00081.1","journal-title":"Int J Part Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.03.036","article-title":"Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia","volume":"160","author":"Cao J","year":"2021","unstructured":"Cao J, Zhang X, Jiang B, et al.. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol. 2021, 160:32-9. 10.1016\/j.radonc.2021.03.036","journal-title":"Radiother Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-D-21-00018","article-title":"Dosimetric results for adjuvant proton radiation therapy of HPV-associated oropharynx cancer","volume":"8","author":"Wright CM","year":"2022","unstructured":"Wright CM, Baron J, Lee DY, et al.. Dosimetric results for adjuvant proton radiation therapy of HPV-associated oropharynx cancer. Int J Part Ther. 2022, 8:47-54. 10.14338\/IJPT-D-21-00018","journal-title":"Int J Part Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.41538","article-title":"Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy","volume":"5","author":"Youssef I","year":"2022","unstructured":"Youssef I, Yoon J, Mohamed N, et al.. Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy. JAMA Netw Open. 2022, 5:e2241538. 10.1001\/jamanetworkopen.2022.41538","journal-title":"JAMA Netw Open"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27308","article-title":"Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy","volume":"45","author":"Pollock AE","year":"2023","unstructured":"Pollock AE, Arons D, Alexander GS, et al.. Gross tumor volume margin and local control in p16-positive oropharynx cancer patients treated with intensity modulated proton therapy. Head Neck. 2023, 45:1088-96. 10.1002\/hed.27308","journal-title":"Head Neck"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang KK","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, et al.. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010, 363:24-35. 10.1056\/NEJMoa0912217","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14112587","article-title":"Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges","volume":"14","author":"Nuyts S","year":"2022","unstructured":"Nuyts S, Bollen H, Ng SP, et al.. Proton therapy for squamous cell carcinoma of the head and neck: early clinical experience and current challenges. Cancers (Basel). 2022, 14:2587. 10.3390\/cancers14112587","journal-title":"Cancers (Basel)"},{"key":"ref30","unstructured":"Particle therapy facilities in clinical operation. (2023). Accessed. July 27, 2023: https:\/\/www.ptcog.site\/index.php\/facilities-in-operation-public."},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0329-x","article-title":"Proton beam therapy in Europe: more centres need more research","volume":"120","author":"Durante M","year":"2019","unstructured":"Durante M. Proton beam therapy in Europe: more centres need more research. Br J Cancer. 2019, 120:777-8. 10.1038\/s41416-018-0329-x","journal-title":"Br J Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2022.11.021","article-title":"Clues to address barriers for access to proton therapy in the Netherlands","volume":"178","author":"Thijssen SV","year":"2023","unstructured":"Thijssen SV, Boersma LJ, Heising L, Swart RR, Ou C, Roumen C, Jacobs M. Clues to address barriers for access to proton therapy in the Netherlands. Radiother Oncol. 2023, 178:109432. 10.1016\/j.radonc.2022.11.021","journal-title":"Radiother Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.11.006","article-title":"Protons in head-and-neck cancer: bridging the gap of evidence","volume":"85","author":"Ramaekers BL","year":"2013","unstructured":"Ramaekers BL, Grutters JP, Pijls-Johannesma M, Lambin P, Joore MA, Langendijk JA. Protons in head-and-neck cancer: bridging the gap of evidence. Int J Radiat Oncol Biol Phys. 2013, 85:1282-8. 10.1016\/j.ijrobp.2012.11.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-20-00042.1","article-title":"Activity-based costing of intensity-modulated proton versus photon therapy for oropharyngeal cancer","volume":"8","author":"Thaker NG","year":"2021","unstructured":"Thaker NG, Boyce-Fappiano D, Ning MS, et al.. Activity-based costing of intensity-modulated proton versus photon therapy for oropharyngeal cancer. Int J Part Ther. 2021, 8:374-82. 10.14338\/IJPT-20-00042.1","journal-title":"Int J Part Ther"},{"key":"ref35","unstructured":"DAHANCA 35. Proton versus photon therapy for head-neck cancer (DAHANCA 35). (2020). Accessed: July 27, 2023: https:\/\/ichgcp.net\/clinical-trials-registry\/NCT04607694."},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.6006","article-title":"Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)","volume":"29","author":"Frank SJ","year":"2024","unstructured":"Frank SJ, Busse P, Rosenthal DI, et al.. Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC). J Clin Oncol. 2024, 29:6006. 10.1200\/JCO.2024.42.16_suppl.6006","journal-title":"J Clin Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison ML","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J, et al.. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019, 393:40-50. 10.1016\/S0140-6736(18)32779-X","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom SS","year":"2021","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ, et al.. Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol. 2021, 39:956-65. 10.1200\/JCO.20.03128","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.06.371","article-title":"Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients: a case-control study","volume":"87","author":"Frank SJ","year":"2013","unstructured":"Frank SJ, Rosenthal DI, Ang K, et al.. Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients: a case-control study. Int J Radiat Oncol Biol Phys. 2013, 87:144. 10.1016\/j.ijrobp.2013.06.371","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00926","article-title":"Quality assessment in supportive care in head and neck cancer","volume":"9","author":"Bonomo P","year":"2019","unstructured":"Bonomo P, Paderno A, Mattavelli D, Zenda S, Cavalieri S, Bossi P. Quality assessment in supportive care in head and neck cancer. Front Oncol. 2019, 9:926. 10.3389\/fonc.2019.00926","journal-title":"Front Oncol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.04.015","article-title":"Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy: a single institutional experience","volume":"104","author":"DeCesaris CM","year":"2019","unstructured":"DeCesaris CM, Rice SR, Bentzen SM, Jatczak J, Mishra MV, Nichols EM. Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy: a single institutional experience. Int J Radiat Oncol Biol Phys. 2019, 104:1084-90. 10.1016\/j.ijrobp.2019.04.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00265-6","article-title":"Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial","volume":"24","author":"Nutting C","year":"2023","unstructured":"Nutting C, Finneran L, Roe J, et al.. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol. 2023, 24:868-80. 10.1016\/S1470-2045(23)00265-6","journal-title":"Lancet Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.07.059","article-title":"Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program","volume":"74","author":"Vergeer MR","year":"2009","unstructured":"Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys. 2009, 74:1-8. 10.1016\/j.ijrobp.2008.07.059","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28672","article-title":"Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module","volume":"120","author":"Rosenthal DI","year":"2014","unstructured":"Rosenthal DI, Mendoza TR, Fuller CD, et al.. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer. 2014, 120:1975-84. 10.1002\/cncr.28672","journal-title":"Cancer"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.08.006","article-title":"Patient- and clinician-reported outcomes in human papillomavirus-associated tonsillar carcinoma treated with unilateral and bilateral intensity modulated radiation therapy-a substudy from TROG 12.01","volume":"115","author":"McDowell L","year":"2023","unstructured":"McDowell L, Rischin D, King M, et al.. Patient- and clinician-reported outcomes in human papillomavirus-associated tonsillar carcinoma treated with unilateral and bilateral intensity modulated radiation therapy-a substudy from TROG 12.01. Int J Radiat Oncol Biol Phys. 2023, 115:174-88. 10.1016\/j.ijrobp.2022.08.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.10.033","article-title":"Quality of life for patients with favorable-risk HPV-associated oropharyngeal cancer after de-intensified chemoradiotherapy","volume":"103","author":"Pearlstein KA","year":"2019","unstructured":"Pearlstein KA, Wang K, Amdur RJ, et al.. Quality of life for patients with favorable-risk HPV-associated oropharyngeal cancer after de-intensified chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2019, 103:646-53. 10.1016\/j.ijrobp.2018.10.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10257","article-title":"Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues","volume":"94","author":"Nguyen NP","year":"2002","unstructured":"Nguyen NP, Sallah S, Karlsson U, Antoine JE. Combined chemotherapy and radiation therapy for head and neck malignancies: quality of life issues. Cancer. 2002, 94:1131-41. 10.1002\/cncr.10257","journal-title":"Cancer"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting CM","year":"2011","unstructured":"Nutting CM, Morden JP, Harrington KJ, et al.. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011, 12:127-36. 10.1016\/S1470-2045(10)70290-4","journal-title":"Lancet Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334672-toxicity-and-oncologic-outcomes-of-proton-radiotherapy-for-oropharyngeal-cancer-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T12:42:00Z","timestamp":1739277720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334672-toxicity-and-oncologic-outcomes-of-proton-radiotherapy-for-oropharyngeal-cancer-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":48,"URL":"https:\/\/doi.org\/10.7759\/cureus.78849","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,11]]}}}